Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
Tag: Edwards Lifesciences
Nurse-led Initiatives Improve Cardiac Care in Underserved Communities
Nurses at nine hospitals developed initiatives to address diverse healthcare challenges in their cardiac surgery critical care or progressive care units, with noteworthy clinical and operational results.
New AACN CSI Academy Cohort at 10 Hospitals Focuses on Underserved Patient Populations
Thanks to a grant from Edwards Lifesciences Foundation, nurses caring for underserved critically ill cardiac patients at 10 U.S. hospitals will participate in a cardiac-focused cohort of AACN Clinical Scene Investigator (CSI) Academy, a nurse leadership and innovation program from the American Association of Critical-Care Nurses.